The agenda includes:
1 Prepare a position paper on the examination of the legitimacy of issuing approvals for reimbursement of foodstuffs for special nutritional use K.Yo chocolate flavours and K.Yo vanilla flavours for the indications: drug-resistant epilepsy, GLUT-1 glucose transporter deficit, pyruvate dehydrogenase deficit.
2. Preparation of a position paper on the appropriateness of issuing reimbursement approvals for the medicinal product Disulone for the indications: Duhring's disease, Sneddon-Wilkinson disease, pemphigoid, linear IgA bullous dermatosis, IgA-related vasculitis, Hailey-Hailey disease, pemphigus, pyoderma gangrenosum, nodular vasculitis, ...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
